<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Clinical Pharmacology News</title> 
<link>http://www.mdlinx.com/ENTLinx/news.cfm/newspage/1/spec_id/30/subspec_id/538</link> 
<description>Clinical Pharmacology</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck]]></title> 
<link>http://www.mdlinx.com/ENTLinx/xml-article.cfm/2942183</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Annals of Oncology</b>]]></description> 
<guid>http://www.mdlinx.com/ENTLinx/xml-article.cfm/2942183</guid>
</item> 
 

<item> 
<title><![CDATA[Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions]]></title> 
<link>http://www.mdlinx.com/ENTLinx/xml-article.cfm/2943339</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Cancer Prevention Research</b>]]></description> 
<guid>http://www.mdlinx.com/ENTLinx/xml-article.cfm/2943339</guid>
</item> 


 

<item> 
<title><![CDATA[Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study]]></title> 
<link>http://www.mdlinx.com/ENTLinx/xml-article.cfm/2945834</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Head &#38; Face Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/ENTLinx/xml-article.cfm/2945834</guid>
</item> 
 
 


  


</channel> 
</rss>

